Nanoprecise Sci Corp | $38,000,000 | (Mar 28, 2025)
Mendel | $35,000,000 | (Mar 28, 2025)
Galatea Bio Inc. | $25,000,000 | (Mar 28, 2025)
Certified by Founder
Lodge
Pathalys Pharma
start up
United States
- Raleigh, North Carolina
- 07/02/2023
- Unknown
- $150,000,000
Pathalys Pharma is a private, late-stage clinical biopharmaceutical company committed to the development of advanced therapeutics that address unmet needs in the management of late-stage chronic kidney disease (CKD). Pathalys was created in partnership with Catalys Pacific and DaVita to become a multi-asset pharmaceutical company focused on the needs of patients with end-stage renal disease.
- Industry Biotechnology Research
- Website https://pathalys.com/
- LinkedIn https://www.linkedin.com/company/pathalys/
MemryX Inc. | $44,000,000 | (Mar 28, 2025)
Mila Beauté | $2,160,000 | (Mar 28, 2025)
Lucky Beverage Co. | $14,200,000 | (Mar 28, 2025)
Taxo (YC S24) | $5,000,000 | (Mar 28, 2025)
BuildVision | $10,000,000 | (Mar 28, 2025)
Yutori | $15,000,000 | (Mar 28, 2025)
Nexthop AI | $110,000,000 | (Mar 27, 2025)
Topanga.io | $8,000,000 | (Mar 27, 2025)
Silna | $27,000,000 | (Mar 27, 2025)